QTTB
Q32 Bio Inc
NASDAQ: QTTB · HEALTHCARE · BIOTECHNOLOGY
$8.82
-4.13% today
Updated 2026-11-12
Market cap
$276.80M
P/E ratio
2.57
P/S ratio
5.15x
EPS (TTM)
$3.60
Dividend yield
—
52W range
$2 – $24
Volume
0.8M
Q32 Bio Inc (QTTB) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$8.82
12-Month target
$7.26
2030 Target
—
Intrinsic (DCF)
$30.38
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $-0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 2.57x (capped 25x) · Margin: 60.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.